2b1p: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The structure-based design and synthesis of a new series of c-Jun, N-terminal kinase-3 inhibitors with selectivity against JNK1 and p38alpha, is reported. The novel series of substituted 6-anilinoindazoles were, designed based on a combination of hits from high throughput screening and, X-ray crystal structure information of the compounds crystallized into the, JNK3 ATP binding active site.
The structure-based design and synthesis of a new series of c-Jun N-terminal kinase-3 inhibitors with selectivity against JNK1 and p38alpha is reported. The novel series of substituted 6-anilinoindazoles were designed based on a combination of hits from high throughput screening and X-ray crystal structure information of the compounds crystallized into the JNK3 ATP binding active site.


==Disease==
==Disease==
Line 21: Line 21:
[[Category: Malmstrom, J.]]
[[Category: Malmstrom, J.]]
[[Category: Ohberg, L.]]
[[Category: Ohberg, L.]]
[[Category: Swahn, B.M.]]
[[Category: Swahn, B M.]]
[[Category: Viklund, J.]]
[[Category: Viklund, J.]]
[[Category: Weigelt, T.]]
[[Category: Weigelt, T.]]
Line 32: Line 32:
[[Category: kinase inhibitor]]
[[Category: kinase inhibitor]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:15:22 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:33:17 2008''